Neuropathologic Alterations in Mild Cognitive Impairment: A Review
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mild cognitive impairment (MCI), the earliest clinically detectable phase of the trajectory toward dementia and Alzheimer's disease (AD), led to the need for even earlier detection and prevention of AD. Although it is a clinical diagnosis, its underlying neuropathological findings are just being defined. MCI is best studied in longitudinally followed patients in centers that are experienced in dementing disorders. In this review of the few major clinical-pathological reports of longitudinally followed patients, it appears that most autopsied amnestic MCI (aMCI) patients are on a pathway toward AD. Neurofibrillary pathology in entorhinal cortex, hippocampus, and amygdala--not amyloid plaques--is the major substrate for aMCI and for memory decline. In addition, many MCI patients have other concomitant pathological alterations, the most common of which are strokes, but also include argyrophilic grains and Lewy bodies. These findings are not surprising because most MCI autopsied cases have been in the older (80 to 90 year) range where these findings are common. In early AD, the phase following MCI, the significant change is an increase in neurofibrillary tangles in the neocortex that correlates with an increase in Braak score and the observed clinical progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AD pathology occurs well before (up to two decades) the onset of clinical symptoms2–4.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
In the citing paper
“It has been estimated that approximately 15 percent of people with aMCI progress to AD annually3.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
In the citing paper
“Indeed, the first pathological insults to neurons in AD and aMCI occur at pre- and post-synaptic membranes1,3.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 4×
“The National Institute on Aging and Reagan Institute (NIA-RI) criteria, developed in 1997 [9], use the CERAD plaque score and the Braak and Braak score to reach a likelihood of the diagnosis of AD.”
ResultInfluentialMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 1×
“[2] in two seminal publications to describe that the”
BackgroundMild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851 · cited 2×
“In another report from Washington University’s Alzheimer’s Disease Research Center [17], they found that in six subjects with CDR scores of 0.5 with uncertain dementia at entry into this study, all had neuropathological AD at autopsy.”
BackgroundInfluentialHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Cited by
Items 101–200 of 235
Ortner, M., Pasquini, L., Barat, M., Alexopoulos, P., Grimmer, T., Förster, S., Diehl‐Schmid, J., Kurz, A., Förstl, H., Zimmer, C., et al. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00132 · Cited by 35
A fuzzy-based system reveals Alzheimer’s Disease onset in subjects with Mild Cognitive Impairment
Tangaro, S., Fanizzi, A., Amoroso, N., & Bellotti, R. (2017) · Physica Medica · doi:10.1016/j.ejmp.2017.04.027 · Cited by 32
Jové, M., Mota‐Martorell, N., Torres, P., Ayala, V., Portero‐Otín, M., Ferrer, I., & Pamplona, R. (2021) · Life · doi:10.3390/life11050388 · Cited by 34
Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.036 · Cited by 31
Tanghe, A., Termont, A., Merchiers, P., Schilling, S., Demuth, H.-U., Scrocchi, L., Van Leuven, F., Griffioen, G., & Van Dooren, T. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/417314 · Cited by 30
“A similar dissociation of amyloid plaque pathology and behavioral aspects was observed in mild cognitive impairment (MCI) patients [34].”
BackgroundNeuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment
Knox, M. G., Adler, C. H., Shill, H. A., Driver‐Dunckley, E. D., Mehta, S. H., Belden, C. M., ZAMRINI, E. Y., Serrano, G. E., Sabbagh, M. N., Caviness, J. N., et al. (2020) · Movement Disorders · doi:10.1002/mds.27991 · Cited by 32
Neuropathology of Parkinson’s Disease
Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 35
“These data in PD-MCI suggest heterogeneous cognitive presentation [ 309 ] and heterogeneous neuropathology similar to that found in MCI cases without PD [ 310 , 311 ].”
ResultMichaelian, J. C., Mowszowski, L., Guastella, A. J., Henry, J. D., Duffy, S. L., McCade, D., & Naismith, S. L. (2019) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617719000870 · Cited by 32
“These neuropathological features are even evident in earlier prodromal phases, specifically in those with mild cognitive impairment (MCI) (Markesbery, 2010).”
BackgroundEffect of common neuropathologies on progression of late life cognitive impairment
Yu, L., Boyle, P. A., Leurgans, S. E., Schneider, J. A., Kryscio, R. J., Wilson, R. S., & Bennett, D. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.006 · Cited by 31
“Neuropathologic diagnoses of Alzheimer’s (AD), cerebrovascular (CVD) and Lewy bodies’ diseases (LBD) are common in older persons (Markesbery, 2010,Rahimi and Kovacs, 2014).”
Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment
Butterfield, D. A. (2023) · Antioxidants · doi:10.3390/antiox12020462 · Cited by 32
“MCI pathology was fully characterized in excellent studies by Markesbery and Morris [14,15], while clinical presentation of MCI has been reported in outstanding reports by”
BackgroundInfluentialInoue, Y., Nakajima, M., Uetani, H., Hirai, T., Ueda, M., Kitajima, M., Utsunomiya, D., Watanabe, M. J. L., Hashimoto, M., Ikeda, M., et al. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4496 · Cited by 30
Aghaei, A., Moghaddam, M. E., & Malek, H. (2022) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.22762 · Cited by 30
Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimers Disease
Nagae, T., Araki, K., Shimoda, Y., Sue, L. I., Beach, T. G., & Konishi, Y. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000441 · Cited by 30
“Some reports have described MCI as a clinical diagnosis, but the underlying neuropathological findings of amnestic MCI, in particular, are just being defined [43,44].”
BackgroundBrain regional synchronous activity predicts tauopathy in 3×TgAD mice
Liu, D., Lu, H., Stein, E. A., Zhou, Z., Yang, Y., & Mattson, M. P. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.016 · Cited by 30
“The Hip is consistently heavily affected by tau pathology and neuronal degeneration in AD, and damage to neurons in this brain region is likely responsible for the early clinical symptoms in AD, namely impaired short-term memory (Markesbery, 2010).”
BackgroundChang, C.-F., Yang, R.-J., Chang, S., Chou, Y. H., & Huang, E.-W. (2016) · Journal of Nursing Research · doi:10.1097/jnr.0000000000000149 · Cited by 29
“5 points lower in patients than in others with similar educational backgrounds, (c) most normal cognitive abilities are not significantly affected, (d) ability to perform activities of daily living (ADLs) is unaffected, and (e) patients do not exhibit mental disease (Markesbery, 2010; Sun et al., 2014).”
BackgroundInfluentialCan mild cognitive impairment be stabilized by showering brain mitochondria with laser photons?
de la Torre, J. C., del Olmo, A., & Vallés, S. L. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107841 · Cited by 27
Ward, A. M., Calamia, M. R., Thiemann, E., Dunlap, J., & Tranel, D. (2016) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2016.1253667 · Cited by 28
“in these regions in patients with AD (Arnold, Hyman, Flory, Damasio, & Van Hoesen, 1991) and MCI (Markesbery, 2010).”
BackgroundMethodYuan, Q., Su, H., Zhang, Y., Chau, W. H., Ng, C. T., Song, Y., Huang, J., Wu, W., & Lin, Z. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122323 · Cited by 29
“Neocortex and hippocampus are the regions of the most vulnerable targets of degeneration in the AD brain [4, 5].”
Augustinack, J. C., Huber, K. E., Postelnicu, G. M., Kakunoori, S., Wang, R., van der Kouwe, A. J. W., Wald, L. L., Stein, T. D., Frosch, M. P., & Fischl, B. R. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0929-5 · Cited by 29
“There is little doubt that the presence of neurofibrillary tangles, more than a few isolated tangles, signifies the person has memory impairment [36].”
BackgroundHonma, T., Hatta, K., Hitomi, Y., Kambayashi, Y., Hibino, Y., Konoshita, T., & Nakamura, H. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3816 · Cited by 26
Towards better interpretable and generalizable AD detection using collective artificial intelligence
Nguyen, H., Clément, M., Mansencal, B., & Coupé, P. (2023) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2022.102171 · Cited by 29
“Third, CN/AD populations seemed to be more distinguishable from each other than sMCI/pMCI populations.”
BackgroundInfluentialLahiri, D. K., & Maloney, B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120373 · Cited by 22
“Progression from MCI through Braak stages of AD correlate with observed neuropathology [31].”
BackgroundLi, W.-B., Zhang, Y.-Z., Chang, C., Wei, X.-E., & Fu, J.-L. (2011) · Neurology India · doi:10.4103/0028-3886.79129 · Cited by 23
Malpas, C. B., Initiative, A. D. N., Saling, M. M., Velakoulis, D., Desmond, P. M., & O'Brien, T. J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142643 · Cited by 23
“Patients with MCI are more likely than elderly controls to carry AD pathology and as such, without accurate in vivo diagnostics, MCI presents the best clinical model of early AD [25].”
Cui, D., Guo, Y., Cao, W., Gao, W., Qiu, J., Su, L., Jiao, Q., & Lu, G. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00612 · Cited by 26
Li, X., Wang, F., Chen, G., Li, X., Yang, Q., Cao, L., & Yan, W.-W. (2016) · AGE · doi:10.1007/s11357-016-9920-3 · Cited by 21
“AD has a long preclinical stage from aging to the emergence of clinical symptoms, and the MCI has been considered the intermediate stage between normal brain aging and dementia (Markesbery 2010; Yi et al. 2015).”
BackgroundSpasov, S. E., Passamonti, L., Duggento, A., Lió, P., & Toschi, N. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/383687 · Cited by 20
Cooperative effects of SIRT1 and SIRT2 on APP acetylation
Li, N., Bai, N., Zhao, X., Cheng, R., Wu, X., Jiang, B., Li, X., Xue, M., Xu, H., Guo, Q., et al. (2023) · Aging Cell · doi:10.1111/acel.13967 · Cited by 23
“AD patients suffer from impairments in cognition, learning, and memory (Braak & Braak, 1991; Markesbery, 2010).”
BackgroundAmnestic mild cognitive impairment with low myocardial metaiodobenzylguanidine uptake.
Sakakibara, R., Ogata, T., Haruta, M., Kishi, M., Tsuyusaki, Y., Tateno, A., Tateno, F., & Mouri, T. (2012) · Europe PMC (PubMed Central) · Cited by 19
Oh, Y.-S., Yoo, S.-W., Lyoo, C. H., Yoo, J.-Y., Yoon, H., Ha, S., Lee, K.-S., & Kim, J.-S. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202496 · Cited by 20
Wu, C., Kupferschmid, A. C., Liu, C., McManus, A. J., Kivisäkk, P., Galler, J. A., Schwab, N. A., DesRuisseaux, L. A., Williams, V. J., Gerber, J. A., et al. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70023 · Cited by 31
Somin, S., Kulasiri, D., & Samarasinghe, S. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00344-2 · Cited by 20
“Intervention is crucial at this stage to ensure aMCI individuals can continue to function well [85].”
BackgroundDepressive Symptoms in Clinical and Incipient Alzheimer’s Disease
Hsiao, J. J., & Teng, E. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.10 · Cited by 19
“40 Markesbery WR. Neuropathologic alterations in mild cognitive impairment: a review. J. Alzheimers Dis. 19(1), 221–228 (2010).”
BackgroundFunctional Hubs in Mild Cognitive Impairment
Navas, A., Papo, D., Boccaletti, S., del Pozo, F., Bajo, R., Maestú, F., Martínez, J. H., Gil, P., Sendiña–Nadal, I., & Buldú, J. M. (2015) · International Journal of Bifurcation and Chaos · doi:10.1142/s0218127415500340 · Cited by 19
Heterogenous mechanisms of mild cognitive impairment in Parkinson’s disease
Jellinger, K. A. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0716-4 · Cited by 17
Ohta, Y., Tremblay, C., Schneider, J. A., Bennett, D. A., Calon, F., & Julien, J.-P. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-37 · Cited by 18
“Although most studies report that levels of β-amyloid (Aβ) and tau pathologies in MCI are intermediate levels between AD and controls [18-20], the neuropathological features of MCI are heterogeneous.”
BackgroundRen, Z., & Mo, L. (2025) · PeerJ · doi:10.7717/peerj.20000 · Cited by 16
“An increase in TMAO levels leads to the accumulation of amyloid-beta (A β ) peptides and hyperphosphorylated tau protein (p-tau) in neuronal cells, representing a major pathogenic mechanism in AD patients ( William, 2010 ).”
Predicting rate of cognitive decline at baseline using a deep neural network with multidata analysis
Candemir, S., Nguyen, X. V., Prevedello, L. M. S., Bigelow, M. T., White, R., & Erdal, B. S. (2020) · Journal of medical imaging · doi:10.1117/1.jmi.7.4.044501 · Cited by 18
Road to Alzheimer’s Disease: The Pathomechanism Underlying
Anand, R., Kaushal, A., Wani, W. Y., & Gill, K. D. (2011) · Pathobiology · doi:10.1159/000332218 · Cited by 24
Kang, D. W., Lim, H. K., Joo, S. H., Lee, N. R., & Lee, C. U. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00245 · Cited by 17
“The brain regions mentioned above show some overlap with the Braak tau stage III/IV, which is understood to be the primary substrate for amnestic MCI (Markesbery, 2010).”
BackgroundChallenges in the Neuropathological Diagnosis of Dementias
Jellinger, K. (2013) · International Journal of Neuropathology · doi:10.7726/ijn.2013.1002 · Cited by 15
“Although cognitively normal elderly may show variable neocortical AD-related pathology, in general, the number of isocortical tangles correlates best with the severity of cognitive impairment (Nelson et al., 2007; Nelson et al., 2009; Markesbery, 2010; Nelson et al., 2012).”
BackgroundLiebe, T., Dordevic, M., Kaufmann, J., Avetisyan, A., Skalej, M., & Müller, N. G. (2022) · Human Brain Mapping · doi:10.1002/hbm.26039 · Cited by 17
“…impairment (MCI) and Alzheimer disease (AD) studies could show an increase of plaques accumulating within the LC, and the relationship of those molecular changes was correlated to the early symptoms and the progression of the disease (Elman et al., 2021; Markesbery, 2010; Tomlinson et al., 1981).”
Xing, Y., Liu, J., Xu, J., Yin, L., Wang, L., Li, J., Yu, Z., Li, F., Gao, R., & Jia, J. (2015) · Disease Markers · doi:10.1155/2015/450237 · Cited by 17
“The longitudinal clinicalpathological studies have identified that aMCI patients are on a pathway toward AD, and 75–80% of aMCI patients finally convert to AD [9].”
BackgroundCaring for Older Adults with Mild Cognitive Impairment: An Update for Nurses
Lin, F. V., Vance, D. E., Gleason, C. E., & Heidrich, S. M. (2012) · Journal of Gerontological Nursing · doi:10.3928/00989134-20121106-03 · Cited by 20
Graph-based deep learning models in the prediction of early-stage Alzheimers
Thapaliya, B., Wu, Z., Sapkota, R., Ray, B., Suresh, P., Ghimire, S., Calhoun, V. D., & Liu, J. (2024) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc53108.2024.10782267 · Cited by 15
“Within this landscape, longitudinal studies emerge as crucial connectors [8], bridging the realms of clinical observation and neuropathological models.”
Is Amnestic Mild Cognitive Impairment a Useful Concept?
Ash, E. L., & Korczyn, A. D. (2011) · Aging Health · doi:10.2217/ahe.10.90 · Cited by 15
“The limited neuropathological data available on predominantly a-MCI patients have shown a spectrum of pathological changes but the most consistent changes are those of AD or mixed dementia [109].”
BackgroundTsentidou, G., Μoraitou, D., & Tsolaki, M. (2021) · Brain Sciences · doi:10.3390/brainsci11050627 · Cited by 14
“These neuropathological features are even obvious in earlier prodromal phases, specifically in stages with mild cognitive impairment (MCI) [20].”
BackgroundPath Integration Detects Prodromal Alzheimer’s Disease and Predicts Cognitive Decline
Hanyu, H., Koyama, Y., Umekida, K., Watanabe, S., Matsuda, H., Koike, R., & Takashima, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240347 · Cited by 13
“27 , 28 In addition to AD pathology (neurofibrillary tangles mainly in the entorhinal cortex and hippocampus, corresponding to Braak stages 3 and 4), underlying brain pathologies of MCI include cerebrovascular lesions, Lewy bodies, TDP-43, argyrophilic grains, and others.”
BackgroundTurchetta, C. S., Simone, M. S. D., Perri, R., Fadda, L., Caruso, G., Tollis, M. D., Caltagirone, C., & Carlesimo, G. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190509 · Cited by 12
Impaired Recognition of Facial and Vocal Emotions in Mild Cognitive Impairment
Moreira, H. S., Costa, A. S., Machado, Á., Castro, S. L., Vicente, S. G., & Lima, C. F. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s135561772100014x · Cited by 13
“MRI studies show structural and functional impairment in medial temporal and posterior cingulate cortices (Markesbery, 2010; Petersen et al., 2014; Tabatabaei-Jafar, Shaw, & Cherbuin, 2015), with some studies reporting more widespread atrophy in temporal and frontal regions (Edmonds et al.”
BackgroundResultInfluentialA whole‐brain functional connectivity model of Alzheimer's disease pathology
Prakash, R. S., McKenna, M. R., Gbadeyan, O., Shankar, A., Pugh, E., Teng, J., Andridge, R., Berry, A. S., & Scharre, D. W. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14349 · Cited by 13
Quenon, L., Dricot, L., Woodard, J. L., Hanseeuw, B. J., Gilis, N., Lhommel, R., & Ivanoiu, A. (2016) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000813 · Cited by 12
“Hippocampal tau-pathology has been reported to be the principal contributor to impaired memory performance in early AD (Markesbery, 2010).”
BackgroundCSF Aβ1–42, but not p-Tau181, differentiates aMCI from SCI
Rizzi, L., Portal, M. M., Batista, C. E. A., Missiaggia, L., & Roriz‐Cruz, M. (2017) · Brain Research · doi:10.1016/j.brainres.2017.10.008 · Cited by 13
Chan, H., Chu, J.-H., Fung, H., Tsai, Y., Meng, L.-F., Huang, C., Hsu, W.-C., Chao, P.-K., Wang, J., Lee, J.-D., et al. (2011) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2011.10.005 · Cited by 15
“AD is characterized by tructural atrophy [1] and the presence of abundant neurofibrilary tangles and senile plaques [2,3].”
BackgroundBraudeau, J., Souchet, B., & Streel, E. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100107 · Cited by 12
Ciarmiello, A., Giovannini, E., Pastorino, S., Ferrando, O., Foppiano, F., Mannironi, A., Tartaglione, A., Giovacchini, G., & Initiative, T. A. D. N. (2022) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004433 · Cited by 12
Puente, A. N., Faraco, C., Terry, D. P., Brown, C. L., & Miller, L. S. (2013) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2013.824065 · Cited by 11
“…perspective, suggesting that MCIs may perform as well as normal OAs behaviorally, but display a greater level of neural activity to overcome underlying neuropathology (Dickerson & Sperling, 2008; Sperling et al., 2010) found in MCI (Braak et al., 1999; Markesbery, 2010; Markesbery et al., 2006).”
BackgroundZhang, X., Lin, W.-M., Xiao, M., & Ji, H. (2021) · Electromagnetic waves · doi:10.2528/pier21051102 · Cited by 11
“Mild cognitive impairment (MCI) is considered a transitional stage between normal control (NC) and dementia [2].”
BackgroundLiu, D., Wang, Z., Shu, H., & Zhang, Z. (2016) · SAGE Open Medicine · doi:10.1177/2050312116648812 · Cited by 10
“5 standard deviations (SDs) from the age- and education-adjusted norms, (3) an MMSE score that was no less than 24 or an MDRS score that was at least 120, (4) preserved activities of daily living, and (5) absence of dementia that was sufficient to meet the National Institute of Neurological and Communicative Disorders…”
MethodRabinovici, G. D. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4143 · Cited by 11
APOE in Alzheimer's disease and neurodegeneration
Butterfield, D. A., & Johnson, L. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104847 · Cited by 10
Questions About Medication Management
Mize, D. (2012) · Journal of Gerontological Nursing · doi:10.3928/00989134-20121106-02 · Cited by 10
Ju, Z., Li, Z., Lu, J., Jiao, F., Lin, H., Bao, W., Li, M., Wu, P., Guan, Y., Zhao, Q., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12101355 · Cited by 9
“The cognitive function of healthy aging depends on maintaining connectivity within and between large-scale networks [31], which can increase the fault tolerance of the network to disease [32].”
BackgroundTsentidou, G., Μoraitou, D., Tsolaki, M., Masoura, E. V., & Papaliagkas, V. T. (2022) · Diagnostics · doi:10.3390/diagnostics12123017 · Cited by 10
“In the ToM deficits disruptions to broader neural networks are likely to be implicated [94] prominent atrophy and tau deposition has been observed in the hippocampus and amygdala, and this may contribute to deficits in social cognition [95,96].”
BackgroundThe Aged Dog as a Natural Model of Alzheimer’s Disease Progression
Araujo, J. A., Baulk, J., & de Rivera, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53219-6_4 · Cited by 9
Cerebrospinal fluid inflammatory markers in amnestic mild cognitive impairment
Rizzi, L., & Roriz‐Cruz, M. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12704 · Cited by 10
Multimodal magnetic resonance imaging analysis of early mild cognitive impairment
Xu, S., Fan, Y., Mao, C., Hu, Z., Yang, Z., Qu, L., Xu, Y., Yu, L., Zhu, X., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251321187 · Cited by 8
“20 Since brain atrophy is apparent in individuals with MCI before the dementia symptoms, 21 identifying volume reduction in characteristic brain areas such as the hippocampus and amygdala in the early stage may contribute to the diagnosis of MCI.”
Mild cognitive impairment in dementia with Lewy bodies: an update and outlook
Jellinger, K. A. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02670-1 · Cited by 9
“However, there is a clear morphological heterogeneity in both MCI-LB and PD-MCI, similar to that in MCI cases without PD (Markesbery 2010).”
ResultPeripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia
Panza, F., Solfrizzi, V., Seripa, D., Imbimbo, B. P., Pilotto, A., & Frisardi, V. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101224 · Cited by 8
“Mild cognitive impairment (MCI) is recognized as a prodromal phase of dementing disorders, and it has been suggested that it could share the same pathological pathways with neurodegenerative processes [3,4].”
BackgroundLuo, P., Kang, G., & Xu, X. (2020) · International Conference on Bioscience, Biochemistry and Bioinformatics (ICBBB) · doi:10.1145/3386052.3386072 · Cited by 8
Assessment of dementia risk in aging adults using both FDG‐PET and FDDNP‐PET imaging
Ercoli, L. M., Small, G. W., Siddarth, P., Kepe, V., Huang, S. ‐., Miller, K. J., Lavretsky, H., Bookheimer, S. Y., Barrio, J. R., & Silverman, D. H. S. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2816 · Cited by 8
“Some amnestic MCI patients who progress to clinical AD do not demonstrate primary AD neuropathology (Jicha et al., 2008; Markesbery, 2010).”
BackgroundNormal Cognitive Aging and Mild Cognitive Impairment: Drawing the Fine Line
Fleming, V. B. (2013) · Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders · doi:10.1044/nnsld23.1.5 · Cited by 9
Neuroimaging features of WOREE syndrome: a mini-review of the literature
Battaglia, L., Scorrano, G., Spiaggia, R., Basile, A., Palmucci, S., Foti, P. V., Spatola, C., Iacomino, M., Marinangeli, F., Francia, E., et al. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1301166 · Cited by 6
“It was observed that the loss of function of the WWOX protein was related to Alzheimer ’ s disease, temporal lobe epilepsy, cognitive impairment, and neuropsychiatric disorders such as autism spectrum disorder (22 – 27).”
BackgroundAlteración cognitiva leve en la práctica clínica
Rodríguez, J. O., & Pareja, F. B. (2010) · Medicina Clínica · doi:10.1016/j.medcli.2010.09.014 · Cited by 6
Malignant Synaptic Growth and Alzheimer‘s Disease
Newman, E. L., Shay, C. F., & Hasselmo, M. E. (2012) · Future Neurology · doi:10.2217/fnl.12.47 · Cited by 8
“Indeed, there are cases in which patients with no cognitive impairment or only mild cognitive impairment, that nonetheless are found to have similar densities of senile plaques during postmortem exam ination as Alzheimer’s patients [42], potentially reflecting individuals for which this response compensated for the sy…”
BackgroundAmnestic mild cognitive impairment
Butler, C., & Ahmed, S. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.016 · Cited by 6
A Parallel Machine Learning Framework for Detecting Alzheimer’s Disease
Knox, S., Chen, T., Su, P., & Antoniou, G. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-86993-9_38 · Cited by 5
“MCI is the "transitional stage between age-related cognitive decline and AD" [15].”
BackgroundInfluentialAttention-Based 3D ResNet for Detection of Alzheimer’s Disease Process
Liu, M., Tang, J., Yu, W., & Jiang, N. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-92185-9_28 · Cited by 7
Cammisuli, D. M., Tuena, C., Riva, G., Repetto, C., Axmacher, N., Chandreswaran, V., Isella, V., Pomati, S., Zago, S., Difonzo, T., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020192 · Cited by 5
“Neu-rofibrillary AD pathology in the entorhinal cortex and hippocampus also represent the neuropathological substrate of memory decline [42] and defective PPI [43].”
BackgroundMild Cognitive Impairment in Parkinson’s Disease: A Critical Update
Jellinger, K. A. (2011) · Aging Health · doi:10.2217/ahe.10.80 · Cited by 4
“The study emphasized the necessity for further studies on the underlying pathologies and the risks of different subtypes of PD-MCI for progression to dementia, as well as to explore the efficacy of treatments, in contrast to non-PD-related MCI [15].”
BackgroundResultStructural neuroimaging correlates of cognitive status in older adults: A person-oriented approach
Malpas, C. B. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2016.01.025 · Cited by 6
Mild cognitive impairment: Challenges in research and in practice
Okhravi, H. R., & Palmer, R. M. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79a.12109 · Cited by 4
Jiang, X., Wu, L., Zhou, R., Quan, M., & Xiang, X. (2025) · Biochemistry and Cell Biology · doi:10.1139/bcb-2025-0058 · Cited by 3
Xiong, L., Li, Q., Zhou, X., Xiao, J., Yang, X., Xu, H., & Guo, C. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241312970 · Cited by 4
“37 Considering that patients with MCI had a high risk of progressing to early AD and extensive oxidative damage in MCI might precede evident AD neuropathological changes, these fi ndings strongly indicated that oxidative imbalance emerged in the early stages of AD and might play a central role in AD…”
Conditional functional clustering for longitudinal data with heterogeneous nonlinear patterns
Wang, T., Yu, L., Leurgans, S. E., Wilson, R. S., Bennett, D. A. A., & Boyle, P. A. (2022) · The Annals of Applied Statistics · doi:10.1214/21-aoas1542 · Cited by 4
Ghaderi, S., Mohammadi, S., Fatehi, F., & Initiative, A. D. N. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70548 · Cited by 4
Sainath Reddy, K., Kaleem, A. K., S, S. B. B., Satish, P., Aravind, P., & Eggadi, V. (2013) · Iranian journal of pharmaceutical sciences · doi:10.22037/ijps.v9.40906 · Cited by 6
The Role of the Entorhinal Cortex in Paraphrenia
Casanova, M. F. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0109-7 · Cited by 7
Development and validation of a model to predict the progression of Alzheimer’s disease
Chu, C., Wang, Y., Huynh, A. L. H., Ng, K. W., Liu, S., Ji, G., Doecke, J. D., Fripp, J., Masters, C. L., Goudey, B., et al. (2025) · Age and Ageing · doi:10.1093/ageing/afaf198 · Cited by 2
“However, the disease exhibits considerable heterogeneity, with cognitive decline varying significantly amongst individuals [6, 7].”
Oxidative Stress and Antioxidant Strategies in Human Diseases
Yuan, K., & Zhang, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-0522-2_1 · Cited by 3
Kim, H. H., Kwon, M. J., Jo, S., Park, J. E., Kim, J. W., Kim, J. H., Kim, S. E., Kim, K. W., & Han, J. W. (2024) · Scientific Reports · doi:10.1038/s41598-024-60843-8 · Cited by 3
“For example, patients with MCI showed an increase in the precuneus, superior parietal cortex, and supra-marginal gyrus activation in both memory and non-memory tasks 48–50 .”
BackgroundInfluentialLi, M., Flack, N., & Larsen, P. A. (2024) · Biomolecules · doi:10.3390/biom14121518 · Cited by 3
Ward, R. J. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735896-00031 · Cited by 2
Séguin, D., KHAN, A. R., & Duerden, E. G. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2409-8_14 · Cited by 2
A putative founder effect for Parkinson’s disease in South African Afrikaners
Carr, J. A., & van Coller, R. (2014) · South African Medical Journal · doi:10.7196/samj.8390 · Cited by 2
Malpetti, M., & Rabinovici, G. D. (2023) · Neurology · doi:10.1212/wnl.0000000000207935 · Cited by 2
Biomarkers for Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Imaging
Bozzali, M., & Serra, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_12 · Cited by 1
Improve 3D Feature Extraction and Fusion for Stage Diagnosis of Alzheimer’s Disease
Liu, M., Yu, W., Tang, J., Jiang, N., Xu, K., & Liu, C. (2022) · IEEE International Symposium on Circuits and Systems proceedings · doi:10.1109/iscas48785.2022.9937344 · Cited by 1
“Mild Cognitive Impairment (MCI) is a transitional stage between nomal elderly cognitive decline and AD, and it is also the earliest clinically detectable stage in the progression of AD [4].”
BackgroundGlimpses of the Living Brain with Alzheimer's Disease
Killiany, R. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch17 · Cited by 1
Proton Magnetic Resonance Spectroscopy for Dementia
Shiino, A. (2017) · Springer eBooks · doi:10.1007/978-4-431-55133-1_7 · Cited by 1
Metadata
- Authors
- Markesbery, W. R.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Markesbery, William R.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 221-228
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC2872776
- OpenAlex
- W1554171816
- Cited by
- 236
- References
- 35
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 12 · 2021: 16 · 2020: 18 · 2019: 8 · 2018: 11 · 2017: 14 · 2016: 16 · 2015: 17 · 2014: 13 · 2013: 17 · 2012: 22
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (P30AG028383, P01AG005119, AG0 5119)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- mild cognitive impairment, Alzheimer's disease
- MeSH terms
- Age Factors, Alzheimer Disease, Animals, Cognition Disorders, Humans, Neurofibrillary Tangles, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.